Abstract ATP and adenosine are important signaling molecules involved in vascular remodeling, retinal function, and neurovascular coupling in the eye. Current knowledge on enzymatic pathways governing the duration and magnitude of ocular purinergic signaling is incompletely understood. By employing sensitive analytical assays, this study dissected ocular purine homeostasis as a complex and coordinated network. Along with previously characterized ecto-5′-nucleotidase/CD73 and adenylate kinase activities, other enzymes have been identified in vitreous fluids, including nucleoside triphosphate diphosphohydrolase (NTPDase), adenosine deaminase, and alkaline phosphatase. Strikingly, activities of soluble adenylate kinase, adenosine deaminase, ecto-5′-nucleotidase/CD73, and alkaline phosphatase, as well as intravitreal concentrations of ATP and ADP, were concurrently upregulated in patients suffering from diabetic retinopathy (DR) with non-clearing vitreous hemorrhage (VH), when compared to DR eyes without VH and control eyes operated due to macular hole or pucker. Additional histochemical analysis revealed selective distribution of key ecto-nucleotidases (NTPDase1/CD39, NTPDase2, ecto-5′-nucleotidase/CD73, and alkaline phosphatase) in the human sensory neuroretina and optic nerve head, and also in pathological neofibrovascular tissues surgically excised from patients with advanced proliferative DR. Collectively, these data provide evidence for specific hemorrhage-related shifts in purine homeostasis in DR eyes from the generation of anti-inflammatory adenosine towards a pro-inflammatory and proangiogenic ATP-regenerating phenotype. In the future, identifying the exact mechanisms by which a broad spectrum of soluble and membrane-bound enzymes coordinately regulates ocular purine levels and the further translation of purine-converting enzymes as potential therapeutic targets in the treatment of proliferative DR and other vitreoretinal diseases will be an area of intense interest.
Introduction
Clear signaling roles for extracellular ATP, ADP, and adenosine have been established in virtually all organs and tissues [1] , including the eye [2, 3] . ATP released from damaged neurons and activated microglia generally acts as a proinflammatory molecule initiating immunomodulatory, neurodegenerative, and hyperemic processes in the eye, which are mediated via activation of P2X7, P2Y 1 , and other ligandgated (P2X) and G protein-coupled (P2Y) receptor subtypes co-expressed in the sensory retina and other ocular structures [2, [4] [5] [6] [7] [8] [9] . Another mechanism of ATP action comprises its ectoenzymatic breakdown into adenosine, which in turn, mediates multiple effects (often counteracting to ATP) via binding to its own nucleoside-selective receptors. A 2A and other subtypes of adenosine receptors were shown to be implicated in the modulation of the light responses of photoreceptors, retinal hyperemia, pathological retinal angiogenesis, protection of neurons from hyper-excitation and glutamate toxicity [3, [10] [11] [12] [13] . Previous research from our and other laboratories revealed the ability of VF and aqueous humor to maintain ATP and adenosine at certain characteristic nanomolar levels, which increase in pathological conditions, such as dry eye disease [14] , glaucoma [2, 12, 15] , age-related macular degeneration with subretinal hemorrhage [4] , and diabetic retinopathy (DR) [16, 17] .
DR is the most common microvascular complication of diabetes worldwide, characterized by visual impairment, vascular leakage, vessel occlusion, neuronal and glial dysfunctions, and cell death in retinal capillaries. The growth of newly formed abnormally differentiated vessels and non-clearing vitreous hemorrhage (VH) are clinical hallmarks in the proliferative form of DR (PDR) [18] [19] [20] [21] [22] [23] . Treatments for the visionthreatening complications of DR have been greatly improved over the past decade. However, further development of preventional and interventional strategies against DR requires a better understanding of the exact mechanisms underlying diabetes-induced microvascular, neurodegenerative and inflammatory complications.
This study aims to further elaborate the role of purinergic mechanisms in the pathogenesis of DR. We have identified a broad spectrum of soluble and membrane-bound enzymes, which are co-expressed in the human VF, sensory retina and optic nerve head and coordinately regulate ocular nucleotide and nucleoside levels via two counteracting, purineinactivating and ATP-regenerating, pathways. Furthermore, data on marked upregulations of intravitreal adenylate kinase (AK), ecto-5′-nucleotidase/CD73 (eN/CD73), adenosine deaminase (ADA), and alkaline phosphatase (ALP) activities and concurrently elevated ATP/adenosine ratio in DR eyes with VH provide a sufficient justification for reexamination of the role of purine homeostasis in the pathogenesis of DR.
Materials and methods

Surgical collection of vitreous samples and PDR neovascular tissues
A total of 136 DR patients and non-diabetic controls operated due to a quiescent idiopathic macular hole (MH) or pucker have been recruited to the original study (Table 1) . Signed informed consent was obtained from each participant before insertion in the study. Clinical surgical enrollment criteria for The patients were sub-grouped as follows: non-diabetic eyes operated due to nonvascular vitreoretinal diseases, including quiescent idiopathic macular hole (MH) or pucker, as well as the diabetic group comprising of patients with proliferative (PDR) and non-proliferative (NPDR) forms of diabetic retinopathy. Prolonged vitreous hemorrhage (>2 months) has been used as an additional surgical enrolment criteria for distinguishing between the eyes without (NH) and with (VH) non-clearing hemorrhage. The levels of glycated hemoglobin A1c (HbA1c) in the whole blood and data on diabetes mellitus (DM) duration were available for the indicated patient number, as specified in the parentheses. Data are presented as mean ± SEM diabetic vitrectomy were severe prolonged VH (> 2 months), traction retinal detachment or severe cystic macular edema with vitreous traction. VF samples were collected by a vitreoretinal surgeon at the start of the conventional threeport pars plana vitrectomy without an infusion of artificial fluid, as described elsewhere [24] . Additional information on vitreous collection and processing can be found in the Supplementary Material. For the preparation of serum, blood was drawn from the antecubital vein and allowed to clot before centrifugation (10 min at 1500g). Undiluted vitreous and serum aliquots were transferred into Eppendorf tubes and immediately frozen and stored at − 70°C until laboratory analysis. Neovascular specimens were also excised surgically from vitrectomized eyes of two PDR patients during vitrectomy, using segmentation and delamination, cut with microscissors, and removed from the vitreous cavity with intraocular endgripping microforceps (MaxGrip Alcon Laboratories), as described previously [22] . Extreme care was placed to remove intact, undamaged neovessels without causing damage to the optic nerve or temporal vascular arcade. The studies were conducted according to the principles of the Declaration of Helsinki and approved by the Institutional Review Board of the Helsinki University Central Hospital and the Ethical Committee.
Preparation of human eye and PDR neovascular tissue sections
Cadaver eyeballs were enucleated 48 h postmortem from a female donor without apparent eye diseases. The use of human tissues and organs has been approved by the Ethical Committee of Turku University Hospital. Transverse sections of the retrobulbar optic nerve close to the optic nerve head, as well as neovascular tissues (excised surgically from PDR patients as described above), were embedded in the cryo-mold with Tissue-Tek® O.C.T. compound (Sakura Finetek Europe B.V. The Netherlands), cut using a cryostat and stored at − 80°C. Eyeballs were additionally enucleated from a 68-yearold patient having a periocular tumor which was estimated to be invading to the bulbus. Immediately after the enucleation, the eyeballs were fixed in 10% formalin for 2-3 days followed by embedding in paraffin according to a routine protocol. Experienced pathologists confirmed that the tumor invasion had not reached the eyeball. The tenets of the Declaration of Helsinki and Kuopio University Hospital ethical rules were followed. 3) in the absence or presence of a specific ALP inhibitor tetramisole (5 mM). After a 60-min pre-treatment, 20 μl of chromogenic substrate for ALP, p-nitrophenyl phosphate (p-NPP), was added to the microwells at a final concentration of 3 mM, followed by incubation at 37°C for 20 h and subsequent measurement of the absorbance intensity at 405 nm (Tecan Infinite M200, Salzburg, Austria). Likewise, serum ALP activity was determined after a 3-h incubation of human serum (2 μl) with 3 mM p-NPP.
Measurement of soluble purine-converting activities
Determination of ATP, ADP, adenosine, and HbA1c
Intravitreal purine concentrations were determined by using bioluminescent (ATP and ADP) and fluorometric (adenosine) enzyme-coupled purine-sensing assays [28] , under the conditions delineated experimentally for VF [16] . After defrosting, VF samples were immediately heat-inactivated for 5 min at 65°C, thus preventing further metabolism of endogenous purines through soluble purinergic enzymes. The protein concentration was determined using the BCA Protein Assay Kit (Pierce, Rockford, IL). Glycated hemoglobin A1c (HbA1c) was measured in the blood using the Tina-quant® HbA1c assay kit with the Cobas Integra-800 analyzer (Roche Diagnostics, Rotkreuz, Switzerland).
Immunohistochemical analysis of ecto-nucleotidases in the human eye
Formalin-fixed, paraffin-embedded sections of the human retina were stained for ecto-nucleotidases using UltraView DAB Detection Kit and BenchMark XT automated slide staining system (Ventana Medical Systems Inc., Roche, USA), according to manufacturer's instructions. For immunofluorescence staining, cryosections of the optic nerve head and neovascular tissues were sequentially incubated with primary and secondary fluorescently labeled antibodies. Additional details are given in the Supplementary Material.
Enzyme histochemistry
For localization of ecto-nucleotidase activities, a modification of the lead nitrate method was employed [29, 30] , as described in the Supplementary Material. ALP activity was additionally evaluated by measuring dark purple precipitate after incubating the tissues at alkaline pH with artificial chromogenic enzyme substrates 5-bromo-4-chloro-3-indolyl-phosphate/nitro blue tetrazolium (BCIP/NBT, 0.35 mM each) [30] .
Statistical analysis
Two-tailed paired Student's t test was used for single comparisons and one-way ANOVA with Dunnett's multiple comparison post-hoc tests for multiple comparisons. Nonparametric Spearman's correlation coefficients were computed to investigate the inter-correlations of continuous variables. In the case of comparative studies, the researcher(s) analyzed the encoded vitreous samples provided by the surgeon in a masked way, without knowing the clinical status of the patients. The results were analyzed with Prism GraphPad 7 software (San Diego, CA) and presented either as column bars (mean ± SEM) or as box-and-whiskers plots, where the box extends from the 25th to the 75th percentile with a horizontal line at the median and with whiskers showing the range of the data. The statistical significance levels were denoted as *P < 0.05 and **P < 0.01.
Results
A broad network of soluble enzymes co-exists in human vitreous and regulates intravitreal purine levels via counteracting, purine-inactivating and ATP-regenerating, pathways
This study was undertaken to characterize the major purineconverting pathways in human vitreous. As shown in Fig. 1a , incubation of VF with [ significantly upregulated in NPDR eyes. Additional comparative analysis of the corresponding soluble enzymatic activities in serum samples from diabetic and non-diabetic patients did not reveal any differences among the groups studied ( Fig. 2a-e; right panels). These data suggest that the observed upregulation of intravitreal enzymes occurs locally in DR eyes and is not accompanied by concurrent shifts in intravascular purine homeostasis in the systemic circulation. These findings are consistent with previous observations showing markedly increased intravitreal AK activities in PDR patients [17] , and further demonstrated that other soluble enzymes (eN/CD73, ADA, and ALP) also became significantly upregulated in DR eyes.
We also pooled the obtained AK data with similar activities determined previously under the same experimental settings in another cohort of patients operated due to DR (n = 86) and MH/pucker (n = 31) [17] . This combination allowed us to perform a more thorough and extended analysis of AK activities among the diabetic and non-diabetic groups. Surprisingly, intravitreal AK was shown to be selectively up-regulated only in DR eyes with severe prolonged VH, with no gender-or DM type-specific variations in the measured nucleotide-phosphorylating activities being observed within the subgroups studied ( Supplementary Fig. S1 ). These data suggest that VH itself, rather than PDR, serves as a key determining factor associated with deregulated purine homeostasis in diabetic eyes. In fact, the performance of a new subgroup analysis based on this emerging criterion revealed high levels of eN/CD73, ADA, AK, and ALP in DR eyes with VH, which significantly exceeded respective soluble activities in DR eyes without VH and also in non-diabetic controls (Fig. 3a) . Notably, all enzymatic activities were expressed as nanomoles of substrate(s) converted by 1 ml of fluid per hour. Additional spectrophotometric analysis did not reveal any differences in total intravitreal proteins among the groups studied, being equal to 5.10 ± 0.34 (mean ± SEM; n = 48), 4.94 ± 0.33 (n = H]Ado (10 μM), as preferred substrates for NTPDase, eN/CD73, adenylate kinase (AK), and adenosine deaminase (ADA), respectively. Alkaline phosphatase (ALP) activity was also determined spectrophotometrically using an artificial enzyme substrate p-NPP (3 mM). The samples were pretreated without (Control) and with the indicated concentrations of certain enzyme inhibitors prior to the addition of substrates. The ordinates show specific activities expressed as nanomoles of substrates converted by 1 ml of fluid per hour (mean ± SEM, n = 4). *P < 0.05 and **P < 0.01, determined by Student's t test (paired, two-tailed) 32 ) and 5.34 ± 0.16 (n = 56) mg/ml in the DR eyes with and without VH, as well as control MH/pucker eyes, respectively. These data allowed excluding the possibility that the revealed upregulation of soluble enzymatic activities might be due to the increased amounts of bulk proteins released into the vitreous cavity during VH, vascular leakage, diabetic tractional retinal detachment, or cell death.
High intravitreal AK correlates with concurrently upregulated ADA activity and increased levels of ATP and ADP in DR eyes with VH By nonparametric correlation analysis, we demonstrated the existence of a positive correlation between soluble AK and ADA activities in DR eyes with VH. eN/CD73 correlated with ALP both in diabetic and non-diabetic eyes and in addition, there was a significant inverse correlation between eN/CD73 and ADA activities in nonhemorrhagic DR eyes (Fig. 3b, c) . Soluble purinergic activities were further correlated with ATP, ADP, and adenosine levels determined in the same vitrectomized eyes. Compared to diabetic eyes without VH and non-diabetic controls, DR eyes with VH were shown to maintain significantly increased ATP and ADP, as well as diminished adenosine concentrations (Fig. 4a and Supplementary  Fig. 2S ). Nonparametric correlation analysis demonstrated the existence of highly positive correlations between AK activity and intravitreal ATP and ADP levels in DR eyes with VH ( Fig. 4b; Supplementary Fig. S3 ). Performance of a similar analysis for eN/CD73 revealed significant inverse correlations between this soluble nucleotidase and ATP and ADP levels in DR eyes without VH ( Fig.  4b; Supplementary Fig. S4 ). The interrelations between other soluble enzymes, ADA, and ALP, and intravitreal purines were relatively modest or insignificant both in DR and non-diabetic groups ( Fig. 4b ; Supplementary  Figs. S5 and S6 ).
Immunohistochemical analysis reveals the selective distribution of key ecto-nucleotidases and ALP within the human sensory retina, PDR neovascular tissues, and optic nerve head
The current study was also aimed to characterize the distribution of major ecto-nucleotidases in the sensory retina and in this way, to establish a link between soluble and membraneassociated enzymes in the human eye. The presence of dark retinal pigmented epithelium (RPE) partially interferes with immunohistochemistry of the eye. Nevertheless, clear-cut differences in staining intensities were detected in the presence of antibodies against different nucleotidases (Fig. 5a-d) , as compared with isotype-matched controls (Fig. 5e) . In particular, eN/CD73 was shown to be expressed in the rod-and-conecontaining photoreceptor cells (Fig. 5a) . The results also demonstrated selective compartmentalization of NTPDase1/CD39 (Fig. 5b), NTPDase2 (Fig. 5c) , and ALP (Fig. 5d) in the neouroretinal and subretinal layers, including ganglion cells, blood vessels, choriocapillaris, and RPE.
Cryosections of the neovascular tissues surgically excised from two PDR eyes during vitrectomy, as well as the prelaminar region of the cadaver optic nerve head were Fig. 2 Analysis of soluble purine-converting activities in the vitreous fluids and sera from diabetic and non-diabetic patients. Specific ecto-5′-nucleotidase/CD73 (eN/CD73; a), adenosine deaminase (ADA; b), adenylate kinase (AK; c), NTPDase/ADPase (D), and alkaline phosphatase (ALP; e) activities were determined in the VF and serum samples collected from diabetic patients with non-proliferative (NPDR) and proliferative (PDR) forms of diabetic retinopathy, as well as control non-diabetic patients operated due to macular hole or pucker (MH/Puck). Purineconverting enzymes were assayed either by TLC with 3 H-labeled purine substrates (a-d) or spectrophotometrically using the artificial ALP substrate p-NPP (e). Enzymatic activities are presented as box-and-whiskers plots expressed as nanomoles of substrates converted by 1 ml of fluid per hour. *P < 0.05 and **P < 0.01, determined by one-way ANOVA with Dunnett's multiple comparison test also analyzed using enzyme (immuno)histochemistry. Measurement of ecto-nucleotidase and ALP activities, in combination with immunofluorescence staining, allowed us to pinpoint the distribution of key nucleotideinactivating enzymes within the tissues. Incubation of neovascular tissues with BCIP/NBT (known as preferred chromogenic substrates for ALP [30] ) revealed the development of dark blue precipitates in the connective tissues (Fig. 5f) . Likewise, fairly similar staining patterns were observed by staining the tissues with an anti-ALP antibody ( Fig. 5f ; rightmost panels). Though, lead nitrate-based enzyme histochemistry did not detect any ecto-nucleotidase activities in the tissues studied (data not shown).
Incubation of the optic nerve head with BCIP/NBT revealed the development of blue staining in the pia mater and blood vessels, which was prevented after pre-treating the sections with an ALP inhibitor tetramisole (Fig. 6b) . Furthermore, we have demonstrated the presence of high ATP-and ADP-hydrolysing activities in the central retinal artery and other blood vessels (Fig. 6c) , and further identified NTPDase1/CD39 as a major enzyme responsible for these nucleotidase reactions (Fig. 6d) . The ADPase reaction product can also be seen, albeit faintly in comparison with ATP, in bundles of the optic nerve fibers (Fig. 6b) , thus suggesting the presence of another ATP-inactivating enzyme, NTPDase2. Immunofluorescence staining Fig. 3 Soluble purine-converting activities are selectively up-regulated in diabetic eyes with vitreous hemorrhage. a Intravitreal eN/CD73, ADA, AK, NTPDase/ADPase, and ALP activities were determined in DR eyes without (−) and with (+) VH, as well as from non-diabetic eyes operated due to macular hole or pucker (MH/P). Enzymatic activities are expressed as nanomoles of substrates converted by 1 ml of fluid per hour and presented as box-and-whiskers plots. *P < 0.05 and **P < 0.01, determined by one-way ANOVA with Dunnett's multiple comparison test. (b) Soluble purinergic activities were further correlated with each other.
The most significant interrelations were observed by plotting ADA versus AK and eN/CD73, as well as ALP versus CD73 activities. The graphs display enzymatic activities determined in individual patients, as well as best-fit linear regression lines with 95% confidence intervals. Panel C summarizes the Spearman's correlation coefficients (Spearman r) computed to investigate the relationships between the indicated enzymes measured both in diabetic and non-diabetic eyes. *P < 0.05 and **P < 0.01, determined by the nonparametric two-tailed correlation analysis confirmed that nerve bundle-surrounding microglial cells express NTPDase2 (Fig. 6e) . Enzyme histochemistry assay with AMP (Fig. 6c) , together with an eN/CD73 staining (Fig. 6d, e) revealed that the expression of eN/CD73 in the optic nerve was associated with the meningeal sheath and the connective tissue septa surrounding blood vessels and nerve bundles. These protein localization results allow the consideration of the innermost retina and optic nerve as potential sources of nucleotidases secreted to the vitreous cavity. Moreover, the pathological neofibrovascular tissue may be considered as yet another source of secreted ALP, contributing to the increased levels of this soluble enzyme in PDR eyes.
Discussion
Purinergic signaling has become an area of renewed focus for both basic research and drug discovery. This study was undertaken to further elucidate regulatory mechanisms governing purinergic signaling in the human eye. Major findings are highlighted in Fig. 7 and can be summarized as follows: (1) a broad network of purine-converting enzymes was identified in human vitreous, where it coordinately controls purine levels through counteracting ATP-inactivating and ATPregenerating pathways; (2) DR patients with VH contain high soluble AK, ADA, eN/CD73, and ALP activities, thus contributing to the maintenance of chronically elevated ATP/ Fig. 4 Soluble purinergic activities correlate with concurrently increased concentrations of ATP and ADP during diabetic vitreous hemorrhage. VF were collected from non-diabetic patients with macular hole or pucker (MH/pucker), as well as from DR patients, which were further subdivided into groups of non-hemorrhagic eyes (NH) and eyes with VH. a Purine concentrations were assayed using enzyme-coupled bioluminescent (ATP, ADP) and fluorometric (adenosine) sensing assays and presented as box-and-whiskers plots (nmol/L). *P < 0.05 and **P < 0.01, determined by one-way ANOVA with Dunnett's multiple comparison test. b Intravitreal purines were further correlated with soluble AK, eNCD73, ADA, and ALP activities, as indicated. Spearman's correlation coefficients (Spearman r) were computed to investigate the relationship between soluble enzymatic activities and purine concentrations. Raw correlation analysis data for each particular enzyme are shown in Supplementary Figs . S3-S6. *P < 0.05 and **P < 0.01, determined by the nonparametric two-tailed correlation analysis adenosine ratio; (3) this work additionally points to the selective distribution of key ecto-nucleotidases (NTPDase1/CD39, NTPDase2, eN/CD73, and ALP) within certain ocular structures, including neuroretinal and subretinal layers, the optic nerve head, and pathological PDR neofibrovascular tissues.
We have recently identified soluble intravitreal enzymes, eN/CD73 and AK (mainly comprising of the AK1 isoform) and further demonstrated that AK activity was selectively upregulated in PDR eyes, accompanied by concurrently elevated concentrations of ATP, ADP, angiopoietin-2, TGFβ1, MMP-9, and other inflammatory and angiogenic factors [17] . The current study extends the earlier findings by showing that, along with eN/CD73 and AK, other soluble enzymes NTPDase/ADPase, ADA, and ALP circulate in the human vitreous. Strikingly, by dividing the VF based on nonclearing VH as additional clinical enrollment criteria for diabetic vitrectomy, we revealed highly specific upregulations of soluble AK, ADA, eN/CD73, and ALP activities in DR eyes with VH (see Fig. 3a) .
Another salient finding of this study is the identification of an extensive network of ocular membrane-bound ectoenzymes. Previous histochemical analyses of human, canine and rodent eyes have shown a selective distribution of ecto-nucleotidases in the retinal vasculature (NTPDase1/ CD39) and parenchyma (NTPDase2) [7, 34, 35] , as well as inner Müller cell processes (eN/CD73) [7, 17, 34, 36] . Here, we have also demonstrated differential localizations of key ecto-nucleotidases in the human ganglion cells (NTPDase2), rod-and-cone-containing photoreceptor layer (eN/CD73), the outer segments of the photoreceptors, retinal vasculature and the adjacent RPE and choriocapillaris layers (NTPDase1/ CD39) (see Fig. 5 ). Abundant expression of nucleotide- Fig. 5 Distribution of ecto-nucleotidases and alkaline phosphatase in the human neuroretina and PDR fibrovascular tissues. Formalin-fixed, paraffin-embedded sections of an enucleated human eyeball were stained with rabbit anti-eN/CD73 (a), α-NTPDase1/CD39 (b), α-NTPDase2 (c), and α-ALP (d) antibodies, as well as with IgG from rabbit serum as a negative control (e). Subsequent microscopic examination reveals a selective distribution of key nucleotide-inactivating enzymes on photoreceptors, the choriocapillaris and other (sub)retinal structures. f Neofibrovascular tissues were surgically excised from two PDR patients and further assayed for ALP activity by using the artificial chromogenic enzyme substrates BCIP/NBT with subsequent monitoring of the development of the blue color reaction. Tissue cryosections were also costained with a rabbit anti-human ALP antibody (cyan) and DAPI (blue), as well as with hematoxylin and eosin (H&E), as indicated. Scale bars: 200 μm (a-e), 500 μm (f) inactivating enzymes in the plane where the retina is cleaved in the living eye during pathological retinal detachment might be of particular relevance in terms of preventing excessive inflammatory responses and maintaining the choroidal and Fig. 6 The distribution of ecto-nucleotidase activities in the human optic nerve head. a Hematoxylin and eosin (H&E) staining of transverse cryosections of the human optic nerve head. CRA, central retinal artery; CRV, central retinal vein; NB, nerve bundles; S, septa; Arac, arachnoid; Dura, dura mater. b Optic nerve cryosections were pre-incubated with or without specific ALP inhibitor tetramisole (tetra; 2 mM) and subsequently incubated with the mixture of artificial chromogenic substrates (BCIP/NBT, 0.35 mM each). A strong ALP-specific dark purple staining can be seen in the pia mater and connective tissue septa. retinal blood supplies via rapid inactivation of locally released ATP. In this context, it is relevant to mention that P2X7 receptors expressed on photoreceptor cells can be implicated in ATP-mediated subretinal hemorrhage, choroidal neovascularization, and photoreceptor cell death [4, 7] , while macrophage/microglial P2X7 seems to act as a scavenger receptor by clearing debris around the RPE and removing metabolic end products from photoreceptors [9] .
Data on the specific distribution of ecto-nucleotidases in the optic nerve head further extend our knowledge on the regulatory mechanisms of purinergic signaling in the human eye. In particular, NTPDase1/CD39 was shown to be expressed in the central retinal artery and other ocular blood vessels. These findings are consistent with data on the abundant expression of NTPDase1/CD39 on vascular endothelial cells and its implication in the control of hemostasis through the termination of pro-inflammatory and pro-thrombotic effects of intravascular ATP and ADP [31, 32, 37] . By contrast, nerve bundle-surrounding microglial cells displayed strong immunoreactivity for NTPDase2. Due to the high preference of NTPDase2 for the hydrolysis of ATP over ADP [31, 32] , this ectoenzyme presumably has functionality in the rapid scavenging of mitogenic extracellular nucleoside triphosphates in a neuronal environment, while the subsequent degradation of ATP-derived ADP into AMP will occur with considerable delay [38] . The identification of eN/CD73 in the connective tissue septa surrounding NTPDase2-positive microglia and NTPDase1/CD39-positive blood vessels suggest the efficient crosstalk between these ecto-nucleotidases, mediating tuned regulation of the ATP-adenosine axis within the optic nerve-fiber bundles and vasculature.
Tissue-nonspecific ALP is known to play a crucial role in bone and cartilage mineralization via the maintenance of the proper concentrations of a powerful mineralization inhibitor PP i [32, 39] and it has also been identified among the top calcification-related genes overexpressed in the human trabecular meshwork [40] . Therefore, the selective expression of ALP in the neurosensory retina and optic nerve head (mainly restricted to the choriocapillaris, pia mater, and small blood vessels and capillaries) may be considered as an important and heretofore unrecognized mechanism controlling blood supply and soft tissue calcification. Furthermore, the presence of ALP in the pathological neofibrovascular tissues surgically excised from PDR eyes (see Fig. 5f ), together with data on significantly upregulated soluble ALP activity in DR eyes without and with VH (see Fig. 3a ) provide a novel insight into the role of this enzyme in the pathogenesis of advanced DR. Though, given a broad substrate specificity of ALP towards different phosphate-containing compounds with a pH optimum for this catalytic reaction lying in the alkaline range [31, 32] , further studies are required to validate the contribution of ALP to the ocular nucleotide homeostasis.
Data on selective compartmentalization of ectonucleotidases in certain ocular structures, together with the identification of a wide spectrum of soluble enzymes coexpressed to a variable extent in human VF, provide novel insights into the regulatory mechanisms governing the duration and magnitude of purinergic signaling in a healthy and diseased eye. Taking into account the fact that the vitreous is the largest structure within the eye occupying about 80% of the ocular volume [41] , the constitutive presence of soluble purine-converting enzymes might represent an important auxiliary effector system for tuned control of balanced nucleotides and adenosine levels in the VF. For instance, eN/CD73 is highly expressed on the photoreceptor cells in human (see Fig. 5a ), canine [36, 42] and rodent [34] retinas, while A 2A receptors are known to be predominantly localized on the inner nuclear layer and ganglion cells facing towards the Fig. 7 Ocular purine homeostasis is upregulated in DR eyes with VH. The cartoon illustrates the fundus of the eye from healthy subjects and patients with MH, as well as from non-proliferative diabetic retinopathy (NPDR) eyes and PDR eyes with prolonged non-clearing vitreous hemorrhage (VH). VH mainly occurs in PDR eyes, which are characterized by the invasion of abnormal blood vessels and neovascularization. The image on the right shows the cross section of the eye and further specifies the selective distribution of different ecto-nucleotidases in the sensory retina, blood vessels, and optic nerve head. The scheme highlights exchange activities of adenine nucleotides and adenosine in human vitreous. Soluble eN/CD73, ADA, AK, and ALP activities are up-regulated in diabetic eyes with VH, thus contributing to the persistent maintenance of high intravitreal concentrations of pro-inflammatory and angiogenic ATP vitreous lumen [11, 36, 43] . These data indirectly imply an important physiological contribution of the soluble forms of eN/CD73 and ADA in controlling local adenosine levels at the vitreoretinal interface. The identification of soluble AK suggests that regulation of ocular nucleotide homeostasis extends beyond the inactivating pathways. AK is abundantly present in the cytosols of well-differentiated tissues with a highenergy demand [44, 45] , including the brain [31, 46] , and rod outer segments of the retina [47] , where it regulates adenine nucleotide pools by catalyzing reversible phosphoryl transfers ATP + AMP ↔ 2ADP. Along with intracellular localization, this ATP-regenerating enzyme is expressed on the surface of vascular endothelial and other cells [31, 33] and it also freely circulates in the human and murine bloodstream [25, 48] , human VF ( [17] ; current study), and rat pancreatic juice [49] . Strikingly, the dramatic activation of AK-mediated phosphotransfer reactions in DR eyes with VH correlates with concurrently elevated concentrations of ATP and ADP (see Fig. 4b ), thus allowing to consider this soluble enzyme as an unfavorable factor triggering spatial propagation of ATPmediated inflammatory responses into the surrounding retina far distant from the site of focal detachment.
These findings prompted important questions regarding the origins of the measured activities and mechanisms underlying their appearance in the vitreous. It may be speculated that certain portions of ocular (ecto)enzymes are co-released into the vitreous cavity, along with ATP and other transmitters, in response to light-evoked neuronal stimulations, mechanical perturbations caused by incessant eye movements and variations in the vascular tone and intraocular pressure. Cellular mechanisms underlying the release of purinergic enzymes might particularly involve the shedding of membrane-bound eN/CD73 and ALP via cleavage of their glycosylphosphatidylinositol anchors, microvesicular shedding, exocytosis, and other secretory pathways [31, 32] . Therefore, in principle, high soluble activities in the DR eyes might reflect a global upregulation of membrane-bound ectoenzymes and their partial shedding into the vitreous lumen. Indeed, the activities of ecto-nucleotidases and other components of the purinergic signaling cascade are known to be activated in the retina under all pathophysiological conditions investigated so far [4, 5, 7, 13] . For instance, the expression of A 2A receptors and the activity of eN/CD73 are upregulated in the inner Müller cell processes during the vasculoproliferative stage of an experimental model of oxygen-induced retinopathy triggered by a 4-day exposure of neonatal dogs to high oxygen and their subsequent return to normal air [36] . Though, our data on markedly activated intravitreal purine homeostasis only in the DR eyes with severe VH suggest the implication of more specific mechanisms triggering the release of soluble enzymes and/or endogenous ATP from the extravascular blood cells and abnormal blood vessels in the course of retinal degeneration, blood clotting, and neovascularization.
Collectively, these data provide evidence for selective VHrelated shifts in purine homeostasis in DR eyes from the generation of anti-inflammatory adenosine towards a proinflammatory and angiogenic ATP-regenerating phenotype. Identifying the exact mechanisms by which the extensive network of membrane-associated and soluble enzymes regulates ocular nucleotide and nucleoside concentrations and the further translation of purine-converting enzymes as potential therapeutic targets in the treatment of proliferative retinopathies with VH and other vascular and degenerative eye diseases will be an area of intense interest in the future.
